Methylprednisolone accelerate chest computed tomography absorption in COVID-19: A three-centered retrospective case control study from China

Table 1 Patient Demographic Characteristics

Indicator		Control group (n = 32)	Glucocorticoid group (n = 38)	summation	χ2 or Hc value	P value
Gender	F	15	15	30	0.389	0.533
	M	17	23	40
Underlying diseases	N	18	23	41	0.131	0.717
	Y	14	15	29
Hypertension	N	24	30	54	0.154	0.695
	Y	8	8	16
Type 2 diabetes	N	28	31	59	0.460	0.498
	Y	4	7	11
Classification	Common type	20	22	42	0.154	0.695
	Severe type	12	16	28
Fever	N	8	4	12	2.562	0.109
	Y	24	34	58
Cough	N	11	13	24	0	0.988
	Y	21	25	46
Polypnea	N	28	26	54	3.586	0.058
	Y	4	12	16
Fatigue	N	22	30	52	0.946	0.331
	Y	10	8	18
Muscle soreness	N	25	36	61	2.924	0.087
	Y	7	2	9
Poor appetite	N	30	34	64	0.043	0.835
	Y	2	4	6
Chest distress	N	29	38	67	1.787	0.181
	Y	3	0	3
Chest pain	N	31	37	68		1
	Y	1	1	2
Diarrhea	N	31	37	68		1
	Y	1	1	2
Throatpain	N	31	38	69		0.457
	Y	1	0	1

F: Female; M: Male.